Although the mechanisms by which merlin suppresses mTOR signaling remain elusive, NF2 inactivation has been found to confer sensitivity to rapalogs in bladder cancer [114], suggesting that mTORC1 signaling likely sustains the expansion of merlin-deficient cancer cells. This evidence concerns the gene NF2 and urinary bladder carcinoma.